Estimated Aggregate Annual Amortization expense for next five years and thereafter (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Estimated Aggregate Annual Amortization expense for next five years and thereafter
Annual amortization 2014	$ 515,810
Annual amortization 2015	452,229
Annual amortization 2016	284,292
Annual amortization 2017	152,841
Annual amortization 2018	46,390
Annual amortization Thereafter	1,711,793
Accumulated amortization Intangible assets CFDA Approved Medical Formulas	507,174
Impairment losses relating to those intangible assets	593,095
Amortization expenses relating to intangible asets was	$ 766,318	$ 611,724

Accumulated amortization Intangible assets CFDA Approved Medical FormulasThe aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives

No definition available.

+ Details

Name:	fil_AccumulatedAmortizationIntangibleAssetsCfdaApprovedMedicalFormulas
Namespace Prefix:	fil_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

amortization expenses recognized during the period and allocated to the reportable segment that results from the write-down of indefinite-lived intangible assets after comparing the implied fair value of reporting unit indefinite-lived intangible assets with the carrying amount of that indefinite-lived intangible assets, which are assessed at least annually for impairment.

+ References

No definition available.

+ Details

Name:	fil_AmortizationExpensesRelatingToIntangibleAsetsWas
Namespace Prefix:	fil_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition